N-Mononitrosopiperazine

N-Mononitrosopiperazine

SCHEMBL1678714

O=NN1CCNCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Mononitrosopiperazine SCHEMBL28228759 0.97
SCHEMBL7972119 0.89
SCHEMBL18650479 0.82 CXCR4 (0.35)
N-Mononitrosopiperazine SCHEMBL28217485 0.77 ADRB1 (0.44)
SCHEMBL3262072 0.75
N,N'-Dinitrosopiperazine SCHEMBL2353649 0.75
Pyrrolidine SCHEMBL11276346 0.75 CA2 (0.35)
Pivalate SCHEMBL19638332 0.74 SIGMAR1 (0.33)
SCHEMBL606668 0.69
SCHEMBL11507080 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361181-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER HSUSTAINABILITY GMBH (DE) 2025-11-27 US claimed
EP-4565543-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER Heidelberg Materials AG (DE) 2025-06-11 EP claimed
CN-118978495-A Preparation method of 1-amino-4-cyclopentyl piperazine 辽宁友之泰医药科技有限公司 2024-11-19 CN claimed
WO-2024028219-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER HEIDELBERG MATERIALS AG (DE) 2024-02-08 WO claimed
EP-4317103-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER Heidelberg Materials AG (DE) 2024-02-07 EP claimed
WO-2013106831-A1 THERMAL DESTRUCTION OF NITROSAMINE IN CO2 CAPTURE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-07-18 WO claimed
US-3997539-A HYPOTENSIVE, TRANQUILIZER AMERICAN HOECHST CORPORATION (US) 1976-12-14 US claimed
JP-8283159-A None JP disclosed
US-20260098021-A1 Nitrosation Reagents and Methods UNIV CALIFORNIA (US) 2026-04-09 US disclosed
CN-114306247-B Pharmaceutical composition containing rifapentine and preparation method thereof 江苏先声药业有限公司 2026-03-06 CN disclosed
US-20250361181-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER HSUSTAINABILITY GMBH (DE) 2025-11-27 US disclosed
US-12459909-B2 Nitrosation reagents and methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-04 US disclosed
EP-4565543-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER Heidelberg Materials AG (DE) 2025-06-11 EP disclosed
US-4797399-A ANTIINFLAMMATORY AGENTS, ANTICOAGULANTS ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-10 US disclosed
EP-0232740-A1 N-containing fused heterocyclic compounds, processes for the preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-08-19 EP disclosed
US-4267175-A FOR USE AS AN ANTIEMETIC, AND TREATMENT FOR GASTROINTESTINAL DISORDERS BEECHAM GROUP LIMITED (GB) 1981-05-12 US disclosed
US-4024258-A Composition of and method for reducing hypertension with a 1-[1-(indol-3-ylethyl)-piperazin-4-yl]-3-substituted urea AMERICAN HOECHST CORPORATION (US) 1977-05-17 US disclosed
US-3997539-A HYPOTENSIVE, TRANQUILIZER AMERICAN HOECHST CORPORATION (US) 1976-12-14 US disclosed
US-3948918-A HYPOTENSIVE AMERICAN HOECHST CORPORATION (US) 1976-04-06 US disclosed
US-3937701-A 1-(10-Cyano/halo-5H-dibenzo[a,d]cyclohepten-5-yl)-4-[(pyridylmethylene)amino]piperazines G. D. SEARLE & CO. (US) 1976-02-10 US disclosed